Suppliers and packagers for advil

advil

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Haleon Us Holdings	ADVIL	ibuprofen	TABLET;ORAL	018989	NDA	Haleon US Holdings LLC	0573-0150-20	1 BOTTLE in 1 CARTON (0573-0150-20) / 24 TABLET, COATED in 1 BOTTLE	1984-05-18
Haleon Us Holdings	ADVIL	ibuprofen	TABLET;ORAL	018989	NDA	Haleon US Holdings LLC	0573-0150-30	1 BOTTLE in 1 CARTON (0573-0150-30) / 50 TABLET, COATED in 1 BOTTLE	1984-05-18
Haleon Us Holdings	ADVIL	ibuprofen	TABLET;ORAL	018989	NDA	Haleon US Holdings LLC	0573-0150-31	1 BOTTLE in 1 CARTON (0573-0150-31) / 75 TABLET, COATED in 1 BOTTLE	1984-05-18

Ibuprofen Drug Supply Chain Analysis

Last updated: February 19, 2026

This report details the supply chain for ibuprofen, a widely used nonsteroidal anti-inflammatory drug (NSAID). The analysis identifies key suppliers of active pharmaceutical ingredients (APIs) and excipients, assesses their geographic distribution, and outlines the regulatory landscape impacting supply. Understanding these elements is critical for stakeholders in drug manufacturing, distribution, and investment.

What is Ibuprofen and Its Market Significance?

Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain, fever, and inflammation. It functions by inhibiting cyclooxygenase (COX) enzymes, which are involved in the synthesis of prostaglandins, signaling molecules that promote inflammation and pain. The global ibuprofen market size was valued at USD 2.5 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 4.5% from 2023 to 2030 (1). This sustained growth underscores its consistent demand and importance in the pharmaceutical sector.

Who are the Primary Suppliers of Ibuprofen API?

The production of ibuprofen API is concentrated among a few major global manufacturers, primarily located in Asia. These companies control significant production capacities, influencing global supply and pricing.

• BASF SE: A German multinational chemical company, BASF is a significant producer of ibuprofen. They operate large-scale manufacturing facilities, ensuring a consistent supply to global markets. Their operations are characterized by stringent quality control and regulatory compliance.
• IOL Chemicals and Pharmaceuticals Ltd. (IOLCP): An Indian pharmaceutical company, IOLCP is one of the world's largest manufacturers of ibuprofen API. They possess substantial production capacity and have established a broad distribution network. Their focus is on cost-effective production while adhering to international quality standards.
• Granules India Ltd.: Another major Indian API manufacturer, Granules India is a key supplier of ibuprofen. The company has diversified its product portfolio but maintains a strong presence in the ibuprofen market, serving both generic and branded pharmaceutical companies.
• Solara Active Pharma Sciences Ltd.: This Indian company also plays a role in the ibuprofen API supply chain. They focus on producing high-quality APIs for regulated markets.

Geographic Concentration of API Manufacturing:

The majority of ibuprofen API production is concentrated in India and China. This geographic concentration presents both advantages in terms of cost efficiency and potential vulnerabilities related to supply chain disruptions.

• India: Holds a dominant position, with companies like IOLCP and Granules India operating at scale. The Indian pharmaceutical industry benefits from a strong regulatory framework, skilled workforce, and established export infrastructure.
• China: Also a significant producer, though specific company names with publicly disclosed ibuprofen API dominance are less consistently highlighted in public domain market analyses compared to Indian counterparts. Chinese manufacturers contribute to global supply, often competing on price.

What are the Key Excipients Used in Ibuprofen Formulations?

Beyond the active ingredient, ibuprofen formulations require various excipients to ensure stability, bioavailability, and ease of administration. The choice of excipients depends on the final dosage form (e.g., tablets, capsules, suspensions).

Commonly Used Excipients:

• Fillers/Diluents: These add bulk to the tablet or capsule, making it a practical size for handling.
  • Microcrystalline Cellulose (MCC): Widely used due to its binding and disintegrant properties.
  • Lactose: Another common filler, though its use is restricted in lactose-intolerant populations.
  • Starch: Derived from corn, potato, or wheat, used for its filler and binder properties.
• Binders: These hold the ingredients together, forming granules or tablets.
  • Povidone (Polyvinylpyrrolidone): A synthetic polymer with excellent binding capabilities.
  • Hydroxypropyl Methylcellulose (HPMC): A versatile binder and film-coating agent.
• Disintegrants: These help the tablet break apart in the digestive tract, releasing the API for absorption.
  • Croscarmellose Sodium: A cross-linked form of carboxymethyl cellulose sodium.
  • Sodium Starch Glycolate: A modified starch that swells rapidly in water.
• Lubricants: These prevent the tablet mixture from sticking to the punches and dies of tablet presses.
  • Magnesium Stearate: The most common lubricant, though alternatives are sought due to potential bioavailability issues.
  • Stearic Acid: Used as a lubricant and as a binder.
• Glidants: These improve the flowability of the powder mixture.
  • Colloidal Silicon Dioxide: Also known as fumed silica, it reduces inter-particle friction.
• Coating Agents: Used for taste masking, protection, or controlled release.
  • Titanium Dioxide: A white pigment for opacity and color.
  • Polyethylene Glycol (PEG): Used as a plasticizer in film coatings.

Suppliers of Excipients:

Excipient suppliers are more geographically dispersed than API manufacturers. Major global chemical and pharmaceutical ingredient companies supply these materials.

• DuPont Nutrition & Biosciences (now IFF): A significant supplier of MCC and other cellulose-based excipients.
• Ashland Global Holdings Inc.: Provides a range of pharmaceutical excipients, including binders and disintegrants.
• Roquette Frères: A global leader in plant-based ingredients, supplying starch derivatives and other functional excipients.
• Evonik Industries AG: Offers a broad portfolio of pharmaceutical excipients, including polymers and specialty ingredients.

What is the Regulatory Framework Governing Ibuprofen Production and Supply?

The production and supply of ibuprofen, like all pharmaceuticals, are subject to stringent regulatory oversight by health authorities worldwide. This framework ensures product safety, efficacy, and quality.

Key Regulatory Bodies and Guidelines:

• U.S. Food and Drug Administration (FDA): Regulates drug manufacturing, approvals, and post-market surveillance in the United States. Compliance with Current Good Manufacturing Practices (cGMP) is mandatory for all drug manufacturing facilities, including API producers. The FDA inspects facilities and reviews drug applications (NDAs, ANDAs).
• European Medicines Agency (EMA): Oversees drug evaluation and supervision in the European Union. Similar to the FDA, the EMA mandates cGMP compliance and conducts inspections. Marketing Authorizations (MAs) are required for drugs sold in the EU.
• Pharmaceuticals and Medical Devices Agency (PMDA) - Japan: The regulatory body for pharmaceuticals and medical devices in Japan.
• Central Drugs Standard Control Organisation (CDSCO) - India: The national regulatory body responsible for the regulation of pharmaceuticals and medical devices in India.
• International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH): Develops guidelines that are adopted by regulatory authorities worldwide. ICH guidelines, such as ICH Q7 (Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients), are critical for API manufacturers.
• Pharmacopeias: Standards set by national and international pharmacopeias (e.g., the United States Pharmacopeia (USP), European Pharmacopoeia (Ph. Eur.)) define the quality, purity, and strength of drug substances and products. Ibuprofen must meet these compendial standards.

Impact of Regulations on Supply Chain:

• Quality Assurance: Regulatory requirements necessitate robust quality control systems at every stage of the supply chain, from raw material sourcing to finished product.
• Facility Inspections: Manufacturers must be prepared for regular inspections by regulatory agencies to ensure ongoing compliance with cGMP. Failure to pass inspections can lead to import alerts or product recalls, disrupting supply.
• Drug Master Files (DMFs): API manufacturers often submit DMFs to regulatory agencies. These confidential documents detail the chemistry, manufacturing, and controls (CMC) of the API, which are then referenced by drug product manufacturers in their marketing applications.
• Supply Chain Transparency: Regulators increasingly demand transparency throughout the drug supply chain, requiring manufacturers to identify and vet all their suppliers.

What are the Risks and Vulnerabilities in the Ibuprofen Supply Chain?

The globalized nature of pharmaceutical manufacturing exposes the ibuprofen supply chain to several inherent risks.

Geopolitical and Economic Risks:

• Concentration of API Manufacturing: The heavy reliance on India and China for API production creates a single point of failure. Geopolitical tensions, trade disputes, or nationalistic policies in these regions can disrupt supply.
• Raw Material Sourcing: The synthesis of ibuprofen involves precursor chemicals, the supply of which may also be concentrated in specific regions. Disruptions in these upstream supply chains can impact API production.
• Economic Instability: Inflation, currency fluctuations, and global economic downturns can affect the cost of raw materials, manufacturing, and logistics, impacting the final price of ibuprofen.

Operational and Environmental Risks:

• Natural Disasters: Earthquakes, floods, or pandemics can impact manufacturing facilities and transportation networks in key producing regions.
• Industrial Accidents: Chemical plant accidents, fires, or explosions at manufacturing sites can halt production and lead to supply shortages.
• Logistics and Transportation: Port congestion, shipping container shortages, and rising fuel costs can delay shipments and increase lead times for both API and finished drug products.
• Quality Control Failures: Despite stringent regulations, lapses in quality control can lead to batch rejections, recalls, and supply interruptions.

Regulatory and Compliance Risks:

• Changes in Regulations: New or updated regulations regarding manufacturing standards, environmental controls, or import/export procedures can necessitate costly adjustments for suppliers.
• Enforcement Actions: Regulatory agencies can impose sanctions, fines, or import bans on companies found to be non-compliant, affecting their ability to supply.

How Can Supply Chain Resilience Be Enhanced?

To mitigate the identified risks, stakeholders can implement several strategies to enhance the resilience of the ibuprofen supply chain.

Strategies for Enhanced Resilience:

• Supplier Diversification: Pharmaceutical companies should identify and qualify alternative API and excipient suppliers in different geographic regions to reduce over-reliance on single sources or regions.
• Dual Sourcing: Engaging multiple suppliers for critical raw materials and intermediates, even if production is consolidated, can provide backup capacity.
• Inventory Management: Maintaining strategic inventory levels of APIs, excipients, and finished goods can buffer against short-term supply disruptions. This requires a balance to avoid excessive carrying costs.
• Vertical Integration: Some larger pharmaceutical companies may consider partial or full vertical integration, bringing API or key intermediate manufacturing in-house to gain greater control.
• Supply Chain Mapping and Visibility: Implementing advanced analytics and digital tools to map the entire supply chain, from tier-N suppliers, can identify hidden vulnerabilities and improve response times during disruptions.
• Contingency Planning: Developing robust contingency plans for various disruption scenarios, including emergency procurement protocols and alternative logistics solutions.
• Strengthening Relationships with Suppliers: Fostering strong partnerships with key suppliers through long-term contracts and collaborative planning can improve reliability and responsiveness.

Key Takeaways

The ibuprofen supply chain is characterized by a concentration of API manufacturing in India and China, supported by a diverse global network of excipient suppliers. This structure presents efficiencies but also inherent risks related to geopolitical instability, operational disruptions, and regulatory compliance. Pharmaceutical companies and investors must navigate this complex landscape by prioritizing supplier diversification, robust quality assurance, and proactive risk management to ensure consistent product availability and mitigate potential supply chain vulnerabilities.

Frequently Asked Questions

1. Which countries are the primary producers of ibuprofen Active Pharmaceutical Ingredient (API)? India and China are the dominant countries for ibuprofen API production.

2. What are the main types of excipients used in ibuprofen tablets? Common excipients include fillers (e.g., microcrystalline cellulose, lactose), binders (e.g., povidone), disintegrants (e.g., croscarmellose sodium), lubricants (e.g., magnesium stearate), and glidants (e.g., colloidal silicon dioxide).

3. How do regulatory bodies like the FDA and EMA impact ibuprofen supply? These bodies enforce Current Good Manufacturing Practices (cGMP) and require stringent quality control, batch testing, and facility inspections, which directly influence the manufacturing and availability of ibuprofen.

4. What is a significant risk associated with the current ibuprofen API supply chain? The significant risk is the high geographic concentration of API manufacturing, particularly in India and China, which makes the supply vulnerable to regional geopolitical events or natural disasters.

5. What strategies can be employed to enhance the resilience of the ibuprofen supply chain? Strategies include supplier diversification across different regions, dual sourcing for critical materials, maintaining strategic inventory levels, and improving supply chain visibility through digital tools.

Citations

1. Grand View Research. (2023). Ibuprofen Market Size, Share & Trends Analysis Report By Formulation (Tablets, Capsules, Syrups, Suppositories), By Application (Pain Management, Fever Reduction, Anti-inflammatory), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, And Segment Forecasts, 2023 - 2030. https://www.grandviewresearch.com/industry-analysis/ibuprofen-market